{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:17:44Z","timestamp":1790788664920,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China (973 Program)","doi-asserted-by":"crossref","award":["2020YFA0909000"],"award-info":[{"award-number":["2020YFA0909000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001878"],"award-info":[{"award-number":["82001878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771858"],"award-info":[{"award-number":["81771858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830052"],"award-info":[{"award-number":["81830052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871403"],"award-info":[{"award-number":["31871403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["81530053"],"award-info":[{"award-number":["81530053"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010993","name":"Key Laboratory of Bioorganic Chemistry and Molecular Engineering","doi-asserted-by":"crossref","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100010993","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["20QA1406100"],"award-info":[{"award-number":["20QA1406100"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Basic Research of Science and Technology Project in Shenzhen","award":["JCYJ20190808163411340"],"award-info":[{"award-number":["JCYJ20190808163411340"]}]},{"name":"Construction Project of Shanghai Key Laboratory of Molecular Imaging","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00259-021-05218-1","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T20:38:52Z","timestamp":1612471132000},"page":"2749-2760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053"],"prefix":"10.1007","volume":"48","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Nan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-2480","authenticated-orcid":false,"given":"Weijun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"5218_CR1","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"key":"5218_CR2","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/cncr.32065","volume":"125","author":"AK Nooka","year":"2019","unstructured":"Nooka AK, Kaufman JL, Hofmeister CC, Joseph NS, Heffner TL, Gupta VA, et al. Daratumumab in multiple myeloma. Cancer. 2019;125:2364\u201382. https:\/\/doi.org\/10.1002\/cncr.32065.","journal-title":"Cancer."},{"key":"5218_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","volume":"131","author":"N van de Donk","year":"2018","unstructured":"van de Donk N, Richardson PG, Malavasi F. CD38 antibodies in multiple myeloma: back to the future. Blood. 2018;131:13\u201329. https:\/\/doi.org\/10.1182\/blood-2017-06-740944.","journal-title":"Blood."},{"key":"5218_CR4","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17:e328\u2013e46. https:\/\/doi.org\/10.1016\/S1470-2045(16)30206-6.","journal-title":"Lancet Oncol"},{"key":"5218_CR5","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1021\/acs.chemrev.9b00738","volume":"120","author":"W Wei","year":"2020","unstructured":"Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. ImmunoPET: concept, design, and applications. Chem Rev. 2020;120:3787\u2013851. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00738.","journal-title":"Chem Rev"},{"key":"5218_CR6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/1535-7163.MCT-18-0087","volume":"17","author":"W Wei","year":"2018","unstructured":"Wei W, Ni D, Ehlerding EB, Luo QY, Cai W. PET imaging of receptor tyrosine kinases in cancer. Mol Cancer Ther. 2018;17:1625\u201336. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0087.","journal-title":"Mol Cancer Ther"},{"key":"5218_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.trecan.2018.03.009","volume":"4","author":"W Wei","year":"2018","unstructured":"Wei W, Jiang D, Ehlerding EB, Luo Q, Cai W. Noninvasive PET imaging of T cells. Trends Cancer. 2018;4:359\u201373. https:\/\/doi.org\/10.1016\/j.trecan.2018.03.009.","journal-title":"Trends Cancer"},{"key":"5218_CR8","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s00259-020-04784-0","volume":"47","author":"W Wei","year":"2020","unstructured":"Wei W, Jiang D, Lee HJ, Li M, Kutyreff CJ, Engle JW, et al. Development and characterization of CD54-targeted immunoPET imaging in solid tumors. Eur J Nucl Med Mol Imaging. 2020;47:2765\u201375. https:\/\/doi.org\/10.1007\/s00259-020-04784-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5218_CR9","doi-asserted-by":"publisher","first-page":"1801237","DOI":"10.1002\/advs.201801237","volume":"6","author":"W Wei","year":"2019","unstructured":"Wei W, Jiang D, Ehlerding EB, Barnhart TE, Yang Y, Engle JW, et al. CD146-targeted multimodal image-guided photoimmunotherapy of melanoma. Adv Sci (Weinh). 2019;6:1801237. https:\/\/doi.org\/10.1002\/advs.201801237.","journal-title":"Adv Sci (Weinh)"},{"key":"5218_CR10","first-page":"2413","volume":"9","author":"W Wei","year":"2019","unstructured":"Wei W, Jiang D, Rosenkrans ZT, Barnhart TE, Engle JW, Luo Q, et al. HER2-targeted multimodal imaging of anaplastic thyroid cancer. Am J Cancer Res. 2019;9:2413\u201327.","journal-title":"Am J Cancer Res"},{"key":"5218_CR11","doi-asserted-by":"publisher","first-page":"1903595","DOI":"10.1002\/advs.201903595","volume":"7","author":"W Wei","year":"2020","unstructured":"Wei W, Liu Q, Jiang D, Zhao H, Kutyreff CJ, Engle JW, et al. Tissue factor-targeted immunoPET imaging and radioimmunotherapy of anaplastic thyroid cancer. Adv Sci (Weinh). 2020;7:1903595. https:\/\/doi.org\/10.1002\/advs.201903595.","journal-title":"Adv Sci (Weinh)"},{"key":"5218_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1182\/blood-2017-09-807263","volume":"131","author":"E Caserta","year":"2018","unstructured":"Caserta E, Chea J, Minnix M, Poku EK, Viola D, Vonderfecht S, et al. Copper 64-labeled daratumumab as a PET\/CT imaging tracer for multiple myeloma. Blood. 2018;131:741\u20135. https:\/\/doi.org\/10.1182\/blood-2017-09-807263.","journal-title":"Blood."},{"key":"5218_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2967\/jnumed.117.196063","volume":"59","author":"A Ghai","year":"2018","unstructured":"Ghai A, Maji D, Cho N, Chanswangphuwana C, Rettig M, Shen D, et al. Preclinical development of CD38-targeted [(89)Zr]Zr-DFO-daratumumab for imaging multiple myeloma. J Nucl Med. 2018;59:216\u201322. https:\/\/doi.org\/10.2967\/jnumed.117.196063.","journal-title":"J Nucl Med"},{"key":"5218_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1148\/radiol.2020192621","volume":"295","author":"GA Ulaner","year":"2020","unstructured":"Ulaner GA, Sobol NB, O'Donoghue JA, Kirov AS, Riedl CC, Min R, et al. CD38-targeted immuno-PET of multiple myeloma: from xenograft models to first-in-human imaging. Radiology. 2020;295:606\u201315. https:\/\/doi.org\/10.1148\/radiol.2020192621.","journal-title":"Radiology."},{"key":"5218_CR15","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1182\/bloodadvances.2020002603","volume":"4","author":"A Krishnan","year":"2020","unstructured":"Krishnan A, Adhikarla V, Poku EK, Palmer J, Chaudhry A, Biglang-Awa VE, et al. Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab. Blood Adv. 2020;4:5194\u2013202. https:\/\/doi.org\/10.1182\/bloodadvances.2020002603.","journal-title":"Blood Adv"},{"key":"5218_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.7150\/thno.8006","volume":"4","author":"R Chakravarty","year":"2014","unstructured":"Chakravarty R, Goel S, Cai W. Nanobody: the \u201cmagic bullet\u201d for molecular imaging? Theranostics. 2014;4:386\u201398. https:\/\/doi.org\/10.7150\/thno.8006.","journal-title":"Theranostics."},{"key":"5218_CR17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2967\/jnumed.118.224170","volume":"60","author":"Y Xing","year":"2019","unstructured":"Xing Y, Chand G, Liu C, Cook GJR, O'Doherty J, Zhao L, et al. Early phase I study of a (99m)Tc-labeled anti-programmed death ligand-1 (PD-L1) single-domain antibody in SPECT\/CT assessment of PD-L1 expression in non-small cell lung cancer. J Nucl Med. 2019;60:1213\u201320. https:\/\/doi.org\/10.2967\/jnumed.118.224170.","journal-title":"J Nucl Med"},{"key":"5218_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2967\/jnumed.115.162024","volume":"57","author":"M Keyaerts","year":"2016","unstructured":"Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, et al. Phase I study of 68Ga-HER2-nanobody for PET\/CT assessment of HER2 expression in breast carcinoma. J Nucl Med. 2016;57:27\u201333. https:\/\/doi.org\/10.2967\/jnumed.115.162024.","journal-title":"J Nucl Med"},{"key":"5218_CR19","doi-asserted-by":"publisher","first-page":"27055","DOI":"10.1038\/srep27055","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Qi S, Unger M, Hou YN, Deng QW, Liu J, et al. Immuno-targeting the multifunctional CD38 using nanobody. Sci Rep. 2016;6:27055. https:\/\/doi.org\/10.1038\/srep27055.","journal-title":"Sci Rep"},{"key":"5218_CR20","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1021\/acs.molpharmaceut.8b00584","volume":"15","author":"N An","year":"2018","unstructured":"An N, Hou YN, Zhang QX, Li T, Zhang QL, Fang C, et al. Anti-multiple myeloma activity of nanobody-based anti-CD38 chimeric antigen receptor T cells. Mol Pharm. 2018;15:4577\u201388. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00584.","journal-title":"Mol Pharm"},{"key":"5218_CR21","doi-asserted-by":"publisher","first-page":"15293","DOI":"10.1074\/jbc.RA119.010010","volume":"294","author":"QW Deng","year":"2019","unstructured":"Deng QW, Zhang J, Li T, He WM, Fang L, Lee HC, et al. The transferrin receptor CD71 regulates type II CD38, revealing tight topological compartmentalization of intracellular cyclic ADP-ribose production. J Biol Chem. 2019;294:15293\u2013303. https:\/\/doi.org\/10.1074\/jbc.RA119.010010.","journal-title":"J Biol Chem"},{"key":"5218_CR22","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/pro.519","volume":"19","author":"MH Kubala","year":"2010","unstructured":"Kubala MH, Kovtun O, Alexandrov K, Collins BM. Structural and thermodynamic analysis of the GFP:GFP-nanobody complex. Protein Sci. 2010;19:2389\u2013401. https:\/\/doi.org\/10.1002\/pro.519.","journal-title":"Protein Sci"},{"key":"5218_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0301-472x(03)00023-7","volume":"31","author":"S Greenstein","year":"2003","unstructured":"Greenstein S, Krett NL, Kurosawa Y, Ma C, Chauhan D, Hideshima T, et al. Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp Hematol. 2003;31:271\u201382. https:\/\/doi.org\/10.1016\/s0301-472x(03)00023-7.","journal-title":"Exp Hematol"},{"key":"5218_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13550-020-0599-1","volume":"10","author":"M Altai","year":"2020","unstructured":"Altai M, Garousi J, Rinne SS, Schulga A, Deyev S, Vorobyeva A. On the prevention of kidney uptake of radiolabeled DARPins. EJNMMI Res. 2020;10:7. https:\/\/doi.org\/10.1186\/s13550-020-0599-1.","journal-title":"EJNMMI Res"},{"key":"5218_CR25","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1021\/acs.molpharmaceut.7b00298","volume":"14","author":"EB Ehlerding","year":"2017","unstructured":"Ehlerding EB, England CG, Jiang D, Graves SA, Kang L, Lacognata S, et al. CD38 as a PET imaging target in lung cancer. Mol Pharm. 2017;14:2400\u20136. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00298.","journal-title":"Mol Pharm"},{"key":"5218_CR26","doi-asserted-by":"publisher","unstructured":"D'Huyvetter M, De Vos J, Caveliers V, Vaneycken I, Heemskerk J, Duhoux FP, et al. Phase I trial of (131)I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients. J Nucl Med. 2020:jnumed.120.255679. https:\/\/doi.org\/10.2967\/jnumed.120.255679.","DOI":"10.2967\/jnumed.120.255679"},{"key":"5218_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2967\/jnumed.115.156729","volume":"56","author":"KL Chatalic","year":"2015","unstructured":"Chatalic KL, Veldhoven-Zweistra J, Bolkestein M, Hoeben S, Koning GA, Boerman OC, et al. A novel (1)(1)(1)in-labeled anti-prostate-specific membrane antigen nanobody for targeted SPECT\/CT imaging of prostate cancer. J Nucl Med. 2015;56:1094\u20139. https:\/\/doi.org\/10.2967\/jnumed.115.156729.","journal-title":"J Nucl Med"},{"key":"5218_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00259-018-3941-3","volume":"45","author":"L Kang","year":"2018","unstructured":"Kang L, Jiang D, England CG, Barnhart TE, Yu B, Rosenkrans ZT, et al. ImmunoPET imaging of CD38 in murine lymphoma models using (89)Zr-labeled daratumumab. Eur J Nucl Med Mol Imaging. 2018;45:1372\u201381. https:\/\/doi.org\/10.1007\/s00259-018-3941-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5218_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1182\/blood-2018-08-825356","volume":"133","author":"E Zamagni","year":"2019","unstructured":"Zamagni E, Tacchetti P, Cavo M. Imaging in multiple myeloma: how? when? Blood. 2019;133:644\u201351. https:\/\/doi.org\/10.1182\/blood-2018-08-825356.","journal-title":"Blood."},{"key":"5218_CR30","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18:e206\u2013e17. https:\/\/doi.org\/10.1016\/S1470-2045(17)30189-4.","journal-title":"Lancet Oncol"},{"key":"5218_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cpet.2019.03.006","volume":"14","author":"S Kumar","year":"2019","unstructured":"Kumar S, Glazebrook KN, Broski SM. Fludeoxyglucose F 18 PET\/computed tomography evaluation of therapeutic response in multiple myeloma. PET Clin. 2019;14:391\u2013403. https:\/\/doi.org\/10.1016\/j.cpet.2019.03.006.","journal-title":"PET Clin"},{"key":"5218_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","volume":"130","author":"L Rasche","year":"2017","unstructured":"Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, et al. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood. 2017;130:30\u20134. https:\/\/doi.org\/10.1182\/blood-2017-03-774422.","journal-title":"Blood."},{"key":"5218_CR33","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/cancers12061467","volume":"12","author":"C Bailly","year":"2020","unstructured":"Bailly C, Chalopin B, Gouard S, Carlier T, Sa\u00ebc PR-L, Marionneau-Lambot S, et al. ImmunoPET in multiple myeloma\u2014what? so what? now what? Cancers (Basel). 2020;12:1467. https:\/\/doi.org\/10.3390\/cancers12061467.","journal-title":"Cancers (Basel)"},{"key":"5218_CR34","doi-asserted-by":"publisher","unstructured":"Minnix M, Adhikarla V, Caserta E, Poku E, Rockne R, Shively JE, et al. Comparison of CD38 targeted alpha- vs beta-radionuclide therapy of disseminated multiple myeloma in an animal model. J Nucl Med. 2020. https:\/\/doi.org\/10.2967\/jnumed.120.251983.","DOI":"10.2967\/jnumed.120.251983"},{"key":"5218_CR35","first-page":"6007","volume":"11","author":"S Li","year":"2019","unstructured":"Li S, England CG, Ehlerding EB, Kutyreff CJ, Engle JW, Jiang D, et al. ImmunoPET imaging of CD38 expression in hepatocellular carcinoma using 64Cu-labeled daratumumab. Am J Transl Res. 2019;11:6007\u201315.","journal-title":"Am J Transl Res"},{"key":"5218_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","volume":"89","author":"R Nielsen","year":"2016","unstructured":"Nielsen R, Christensen EI, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 2016;89:58\u201367. https:\/\/doi.org\/10.1016\/j.kint.2015.11.007.","journal-title":"Kidney Int"},{"key":"5218_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/cmmi.408","volume":"6","author":"LO Gainkam","year":"2011","unstructured":"Gainkam LO, Caveliers V, Devoogdt N, Vanhove C, Xavier C, Boerman O, et al. Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice. Contrast Media Mol Imaging. 2011;6:85\u201392. https:\/\/doi.org\/10.1002\/cmmi.408.","journal-title":"Contrast Media Mol Imaging"},{"key":"5218_CR38","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.20161950","volume":"214","author":"M Rashidian","year":"2017","unstructured":"Rashidian M, Ingram JR, Dougan M, Dongre A, Whang KA, LeGall C, et al. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med. 2017;214:2243\u201355. https:\/\/doi.org\/10.1084\/jem.20161950.","journal-title":"J Exp Med"},{"key":"5218_CR39","doi-asserted-by":"publisher","first-page":"14289","DOI":"10.1038\/s41598-017-14112-6","volume":"7","author":"W Fumey","year":"2017","unstructured":"Fumey W, Koenigsdorf J, Kunick V, Menzel S, Schutze K, Unger M, et al. Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38(+) tumors in mouse models in vivo. Sci Rep. 2017;7:14289. https:\/\/doi.org\/10.1038\/s41598-017-14112-6.","journal-title":"Sci Rep"},{"key":"5218_CR40","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1073\/pnas.1819745116","volume":"116","author":"J Xu","year":"2019","unstructured":"Xu J, Chen LJ, Yang SS, Sun Y, Wu W, Liu YF, et al. Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed\/refractory multiple myeloma. Proc Natl Acad Sci U S A. 2019;116:9543\u201351. https:\/\/doi.org\/10.1073\/pnas.1819745116.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05218-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T07:06:33Z","timestamp":1625641593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05218-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5218"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05218-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-188294\/v1","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"W. Wei and J. Liu are co-inventors on a provisional patent application (Application No. 202011131233.7) encompassing the technology described in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}